Publication date: Available online 18 June 2018
Source: Journal of Anxiety Disorders
Author(s): Laura Loucks, Carly Yasinski, Seth D. Norrholm, Jessica Maples-Keller, Loren Post, Liza Zwiebach, Devika Fiorillo, Megan Goodlin, Albert A. Rizzo, Barbara O. Rothbaum
Abstract
This initial feasibility study examined the use of virtual reality exposure therapy (VRE) in the treatment of MST-related PTSD, with newly developed content tailored to MST. Participants included 15 veterans (26% male) with MST-related PTSD. Assessment of PTSD, depression, and psychophysiological indicators of distress occurred at pre-treatment, post-treatment, and 3-month follow-up. Treatment included 6-12 VRE sessions. There were significant reductions in pre- to post-treatment PTSD (CAPS severity: t(10) = 3.69, p = .004; PCL-5: t(10) = 3.79, p = .004) and depressive symptoms, (PHQ-9: t(8) = 2.83, p = .022), which were maintained at follow-up. There also was a significant pre- to post-treatment reduction in heart rate response to a trauma cue. Cohen's d effect sizes were large (CAPS: d = 1.11; PCL-5: d = 1.14, PHQ-9: d = .94), and the percentage of participants meeting PTSD criteria continued to decline from post-treatment (53%) to follow-up (33%). Findings indicate VRE can be safely delivered and is a promising treatment for MST-related PTSD.
https://ift.tt/2KTqG1T
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου